Lynx Therapeutics Overview

  • Founded
  • 1992
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 7
  • Investments
  • 1

Lynx Therapeutics General Information

Description

Developer of genetic analysis technologies for pharmaceutical, biotechnology and agricultural industries. The company's cloning and sequencing technologies provide comprehensive and quantitative digital gene expression data which is important to systems biology research enabling drug discovery and development companies to research, develop and implement new treatments for improving human health.

Contact Information

Website
www.lynxgen.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • 25861 Industrial Boulevard
  • Hayward, CA 94545
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lynx Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lynx Therapeutics‘s full profile, request access.

Request a free trial

Lynx Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Kevin Corcoran Board Member, President & Chief Executive Officer
To view Lynx Therapeutics’s complete executive team members history, request access »

Lynx Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lynx Therapeutics‘s full profile, request access.

Request a free trial

Lynx Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 07-Mar-2005 0000000 000000 Biotechnology
To view Lynx Therapeutics’s complete acquisitions history, request access »